Abiopharma

🔍 DUNTON ALAN W (Director)

Company: PALATIN TECHNOLOGIES INC (PTN)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 1,000 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,081.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 1,000 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,081.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 1,200 shares of Stock Option (Right to Buy) at $21.38 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2035-12-09 | Exercise: 2026-12-09 | equity_swap_involved: 0 | shares_owned_after: 24,799.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 1,200 shares of Stock Option (Right to Buy) at $21.38 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2026-12-09 | Exercise: 2026-12-09 | equity_swap_involved: 0 | shares_owned_after: 25,999.00 | transaction_form_type: 4 | Footnotes: F4, F4

Footnotes:

• F1: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.
• F2: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.
• F3: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options.
• F4: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.